MWMatthew Ryan Woodward

Matthew Ryan Woodward

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Matthew Ryan Woodward has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Enhancing the golden hour: classification of traumatic brain injury, severity, and concomitant clinical phenotypes using prehospital continuous physiological data during air transport

    by Matthew R Woodward, Shiming Yang, Mayur Somalinga, Kenneth Dalton, Ryan B Felix, Jamie Podell, Lujie Chen, Gary Schwartzbauer, William Teeter, Doug Floccare, et al.

    Background. During emergency transport, clinical assessment and vital signs (VS) may lack the sensitivity to identify traumatic brain injury (TBI) and identify specific TBI subtypes which may have implications for triaging and timely delivery of life-saving interventions. Objective. To evaluate the ability of machine learning (ML) algorithms to identify the presence of TBI with or without specific important concomitant clinical phenotypes including shock, coagulopathy and polytrauma during air transport to a trauma center. Methods. We identified a cohort of consecutive trauma patients aged 18–65 transported from the scene of injury via helicopter to an urban academic trauma center and collected prehospital clinical data and continuous VSs. We used ElasticNet (regularized regression) and XGBoost (gradient boosting), comparing three variable sets: clinical variables only, continuous physiologic monitoring data only, and combined clinical and physiological data, to develop four predictive models: (1) presence/absence of TBI, (2) mild vs moderate-severe TBI, (3) presence/absence of polytrauma in moderate-severe TBI, (4) presence/absence of coagulopathy in TBI, and (5) presence/absence of shock in TBI. Results. 1025 patients (median age 38, interquartile range (IQR): 27–53; 70% male; median Glasgow coma scale 15 (IQR: 13–15) were identified. Across all predictive models, ML algorithms exhibited good predictive discrimination, with area under the receiver operator curve of 0.79 (0.75–0.84), 0.79 (0.74–0.83), 0.89 (0.85–0.92), 0.77 (0.67–0.86), and 0.78 (0.72–0.84) for TBI, TBI severity, polytrauma, coagulopathy, and shock, respectively. Clinical data best predicted TBI severity and polytrauma, while physiologic data improved prediction of shock and coagulopathy. Conclusions. ML algorithms integrating clinical and continuous physiological monitoring can improve identification of TBI and concomitant clinical phenotypes during prehospital transport.

  • Trends in Status Epilepticus-Related Mortality Disparities in the United States, 1999–2020

    by Wesley Budd, Connor A. Law, Noor F. Shaik, Maria Camitan, Matthew Ryan Woodward, Andrea Lauren Christman Schneider, Emily L. Johnson

    Status epilepticus (SE) is a life-threatening neurologic emergency. Although health disparities in epilepsy are well-documented, disparities in SE mortality are not fully understood. This study analyzes mortality trends and demographics in the United States from 1999 through 2020. This was a retrospective study of national data from the Center for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research platform. We identified annual deaths due to SE for the years 1999 through 2020, stratified by age and by race and ethnicity. From 1999 through 2020, there were 16,491 deaths due to SE in the United States. Overall, there was nearly a 2-fold increase in the age-standardized mortality due to the SE rate from 1999 to 2020 (0.13 per 100,000 persons [95% CI 0.11-0.15] in 1999 to 0.25 per 100,000 persons [95% CI 0.23-0.27] in 2020). This increase was most pronounced among older individuals (aged 75 years and older, followed by ages 50-74 years), and in non-Hispanic Black or African American individuals. Over the past 2 decades, deaths attributed to SE have increased. This increase was most pronounced among individuals aged 75 years or older and Black or African Americans. Investigation into the underlying causes of SE-related mortality and reasons for these disparities is needed.


  • The ICH Bundle Has No Clothes…or Are They Spun From Invisible Threads?

    by Matthew Ryan Woodward, Nicholas A. Morris

  • Super-Refractory Status Epilepticus Diagnosis, Management, and Prognostication

    by Matthew Ryan Woodward, Jessica P. Brown, Steven J. Kittner, Neeraj Badjatia, Emily J. Gilmore, Emily L. Johnson, Nicholas A. Morris

    Guidelines for super-refractory status epilepticus (SRSE) evaluation, management, and prognostication are lacking. Characterization of practice patterns could identify trends and potential areas for future inquiry. We surveyed clinicians who manage SRSE to better understand practice approaches to SRSE evaluation, management, and prognostication. We conducted an international cross-sectional 66-question, web-based survey of clinicians who manage SRSE, distributed through 4 scientific societies from August 3, 2023, through January 25, 2024. We collected data regarding SRSE diagnostics and management. We examined prognostic approaches based on 2 clinical vignettes. We characterized responses using descriptive statistics and developed logistic regression models to identify key factors associated with prognostication. Of 245 participants, 36 were excluded because of no clinical involvement with SRSE and 209 were included; 41 (20%), 66 (32%), and 84 (40%) participants were neurologists, neurointensivists, and general intensivists, respectively, 83% of whom practiced in the United States. For IV anesthetic treatment, midazolam (n = 47, 38%) and propofol (n = 42, 34%) were most often selected as first line while ketamine was most often 2nd (n = 34, 26%) or 3rd (n = 52, 41%) line. Regarding electroencephalography targets for IV treatment, burst suppression (n = 96, 47%) or seizure suppression (n = 70, 34%) was most popular. This goal was maintained for a median of 49.5 hours (interquartile range 29.8-74 hours) before weaning. Regarding prognostication, of 147 respondents, 75 (51%) reported an ability to predict favorable prognosis, which was associated with neurology (OR: 4.4, 95% CI 1.5-13.5) or general intensivist (OR: 4.6, 95% CI 1.6-14) practice vs neurocritical care (reference, fewer than 5 years of experience (OR: 3.9, 95% CI 1.6-10); higher annual SRSE case load (OR: 2.9, 95% CI 1.7-7.3); and use of clinical severity scores (OR: 4.7, 95% CI 2-11.4). Time to determine futility and recommendations for withdrawal of life-sustaining therapy (WLST) followed bimodal distributions, with early (0-4 weeks) and delayed (26 weeks) modes. Prognostic optimism was associated with delayed determination of futility and recommendation for WLST (OR: 6.2, 95% CI 2.2-19.3). There is significant variability in the evaluation and management of SRSE, including treatment preferences, targets, and duration of therapy. Prognostication is associated with multiple clinician-related factors. The timing of prognostication is highly variable and is associated with clinician optimism.


  • Open Access

    Status epilepticus in older adults: A critical review

    by Matthew R. Woodward, Michael J. Armahizer, Tina I. Wang, Neeraj Badjatia, Emily L. Johnson, Emily J. Gilmore

    Older adults (≥60 years of age) have the highest incidence of status epilepticus (SE) among adults and experience the highest morbidity and mortality. SE incidence increases with age in adulthood. A recent study from Austria estimated an incidence of 89.6/100 000 and 67.6/100 000 person‐years adjusted for age and sex in women and men aged >60 years, respectively, compared to 18.1/100 000 in adults aged <60 years. In‐hospital mortality associated with SE increases fourfold from the 3rd to 9th decade of life. There are multiple important considerations unique to older adults. Etiologies, including ischemia, hemorrhage, and neoplasm, are more common in older adults and are independently associated with poorer outcomes. Important physiological changes of aging affect both the pharmacokinetics and pharmacodynamics of established treatments for SE. Pharmacology studies have shown differences in sensitivity to benzodiazepines and benzodiazepine elimination, as well as greater unpredictability of antiseizure medications such as phenytoin. Older adults have been largely underrepresented in high‐quality randomized clinical trials of SE treatment relative to the incidence of SE in this population. The Established Status Epilepticus Treatment Trial published a post hoc analysis of older adults that showed similar efficacy of treatments, although many older trials did not stratify by age, limiting the opportunity to recognize age‐related differences in efficacy and safety. Future research should be aimed at investigating treatment selection and dosing in older adults with SE.


  • Open Access

    Behavioral Assessment With the Coma Recovery Scale—Revised Is Safe and Feasible in Critically Ill Patients With Disorders of Consciousness

    by Matthew R. Do Woodward, Chris L. Wells, Shannon Ba Arnold, Farra Dorman, Zaka Mbbs Ahmed, Nicholas A. Morris, Prajwal Ciryam, Jamie E. Podell, Wan-Tsu W. Chang, W. Denney Do Zimmerman, et al.

    OBJECTIVES: Accurate classification of disorders of consciousness (DoC) is key in developing rehabilitation plans after brain injury. The Coma Recovery Scale—Revised (CRS-R) is a sensitive measure of consciousness validated in the rehabilitation phase of care. We tested the feasibility, safety, and impact of CRS-R-guided rehabilitation in the ICU for patients with DoC after acute hemorrhagic stroke. DESIGN: Retrospective cohort study. SETTING: This single-center study was conducted in the neurocritical care unit at the University of Maryland Medical Center. PATIENTS: We analyzed records from consecutive patients with subarachnoid hemorrhage (SAH) or intracerebral hemorrhage (ICH), who underwent serial CRS-R assessments during ICU admission from April 1, 2018, to December 31, 2021, where CRS-R less than 8 is vegetative state/unresponsive wakefulness syndrome (VS/UWS); CRS-R greater than or equal to 8 is a minimally conscious state (MCS). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Outcomes included adverse events during CRS-R evaluations and associations between CRS-R and discharge disposition, therapy-based function, and mobility. We examined the utility of CRS-R compared with other therapist clinical assessment tools in predicting discharge disposition. Seventy-six patients (22 SAH, 54 ICH, median age = 59, 50% female) underwent 276 CRS-R sessions without adverse events. Discharge to acute rehabilitation occurred in 4.4% versus 41.9% of patients with a final CRS-R less than 8 and CRS-R greater than or equal to 8, respectively (odds ratio [OR] 13.4; 95% CI, 2.7–66.1; p < 0.001). Patients with MCS on final CRS-R completed more therapy sessions during hospitalization and had improved mobility and functional performance. Compared with other therapy assessment tools, the CRS-R had the best performance in predicting discharge disposition (area under the curve: 0.83; 95% CI, 0.72–0.94; p < 0.0001). CONCLUSIONS: Early neurorehabilitation guided by CRS-R appears to be feasible and safe in the ICU following hemorrhagic stroke complicated by DoC and may enhance access to inpatient rehabilitation, with the potential for lasting benefit on recovery. Further research is needed to assess generalizability and understand the impact on long-term outcomes.


  • Open Access

    Comparison of induction agents for rapid sequence intubation in refractory status epilepticus: A single-center retrospective analysis

    by Matthew R. Woodward, Adam Kardon, Jody Manners, Samantha Schleicher, Melissa B. Pergakis, Prajwal Ciryam, Jamie Podell, William Denney Zimmerman, Samuel M. Galvagno, Bilal Butt, et al.

  • Evaluating salvage electroconvulsive therapy for the treatment of prolonged super refractory status epilepticus: A case series

    by Matthew R. Woodward, Seshagiri Doddi, Christopher Marano, William Regenold, Jennifer Pritchard, Stephanie Chen, Megan Margiotta, Wan-Tsu W. Chang, Ayham Alkhachroum, Nicholas A. Morris


  • Secondary Hemophagocytic Lymphohistiocytosis Causing Hemorrhagic Encephalomyelitis and Spinal Subarachnoid Hemorrhage: A Case Report

    by Matthew R. Woodward, Margaret S. Ferris, Guillermo Rivell, Laura Malone, Tara M. Dutta, Haroon Ahmad, Nicholas A. Morris

    We are writing to present an interesting and novel case from our practice of a patient who presented with altered mental status and a rapidly progressive paraplegia as well as high fevers and pancytopenia. A bone marrow biopsy was diagnostic of hemophagocytic lymphohistiocytosis (HLH) and MRI showed hemorrhagic encephalitis and spinal subarachnoid hemorrhage. This case demonstrates the diverse neurological symptoms with which HLH presents, including spinal cord pathology. The astute neurologist should consider this diagnosis in the appropriate clinical context and diagnosis may require imaging to the complete neuraxis.